The 80/20 approach chose four top-ranked molecules (spot#426-PNP, spot#582-KRT1, spot#486-ALB, and spot#662-ACTB), and this model performed better than the CV model in predicting the ChD CS vs. NH subjects. This evidence concerns the gene ACTB and coronary artery disorder.